Evidence map›Paper›PMID 33803385›Full record

ArticleCancers2021

Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp Cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery.

Elia Bari, Massimo Serra, Mayra Paolillo, Eric Bernardi, Sara Tengattini, Filippo Piccinini, Cristina Lanni, Marzio Sorlini, Giovanni Bisbano, Enrica Calleri and 2 more

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elia BariDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0003-0241-0620
Massimo SerraDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0002-6724-4355
Mayra PaolilloDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0002-7751-3336
Eric BernardiDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0003-1488-1673
Sara TengattiniDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0002-8584-5883
Filippo PiccininiIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via Piero Maroncelli 40, I-47014 Meldola, Italy.ORCID 0000-0002-0371-7782
Cristina LanniDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0002-3061-4738
Marzio SorliniDepartment of Innovative Technologies, SUPSI, Lugano University Centre, Campus Est, Via la Santa 1, 6962 Viganello, Switzerland.
Giovanni BisbanoDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0003-2845-3223
Enrica CalleriDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.
Maria Luisa TorreDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0001-8062-6836
Sara PerteghellaDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, Italy.ORCID 0000-0003-1128-7636

Funding

Interreg V-A Italy-Switzerland 2014-2020 : ATEx-Advanced Therapies Experiences. Project ID 637541.
6 · The paper itself

Abstract

Arg-Gly-Asp (RGD)-based cyclopentapeptides (cRGDs) have a high affinity towards integrin αvβ3 and αvβ5, which are overexpressed by many tumor cells. Here, curcumin-loaded silk fibroin nanoparticles (SFNs) have been functionalized on the surface with cRGD to provide active targeting towards tumor cells; a "click reaction" between the RGD-based cyclopentapeptide carrying an azide group and triple-bond-functionalized nanoparticles has been exploited. Both naked and functionalized SFNs were less than 200 nm in diameter and showed a round-shaped morphology but, after functionalization, SFNs increased in size and protein molecular weight. The functionalization of SFNs' surfaces with cRGD provided active internalization by cells overexpressing integrin receptors. At the lowest concentration tested (0.01 mg/mL), functionalized SFNs showed more effective uptake with respect to the naked by tumor cells that overexpress integrin receptors (but not for non-overexpressing ones). In contrast, at higher concentrations, the non-specific cell membrane protein-particle interactions are promoted and coupled to specific and target mediated uptake. Visual observations by fluorescence microscopy suggested that SFNs bind to integrin receptors on the cell surface and are then internalized by endocytosis. Overall, SFN functionalization provided in vitro active targeting for site-specific delivery of anticancer drugs, boosting activity and sparing healthy organs.

Indexed as

active targetinganticancercurcuminRGDsilk fibroin nanoparticles

Identifiers

PMID33803385
PMCPMC7967211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.